Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IQCG | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | VIMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | PRMT8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | BEST4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | ZNF559-ZNF177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | AURKAIP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | STARD8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | FKBP2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | MYO16 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | CLK2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |